Biological vaccination at ecosystem scale—transforming entire environments from disease reservoirs into protective sanctuaries.

ArboShield™ Vectors

The ArboShield™ Numerical Advantage Strategy

During disease outbreaks, only <1% of wild mosquitoes carry the dangerous viruses. The other 99%+ are uninfected and available for beneficial colonization through mating with ArboShield™ mosquitoes.

ArboShield™ mosquitoes are released to overwhelm wild virus spread (10:1 to 100:1 numerical advantage)

ArboShield™ mosquitoes win the mating competition for uninfected mosquitoes, replacing dangerous virus genomes throughout the population.

Dual-Layer Protection: Pathogenic Genome Elimination + Immunity Transfer

Layer 1: Ecosystem Vaccination

• ArboShield™ mosquitoes cannot carry dangerous virus genomes

• ArboShield™ HR-symbionts replace disease-causing viruses in the environment

• Self-sustaining protection requiring no reapplication

Layer 2: Population Immunization

• ArboShield™ mosquitoes transfer pathogen immunity when they bite humans and reservoir animals without causing disease

• Communities develop herd immunity across entire populations, creating a dead-end for virus pathogens

A Self-Sustaining System of Protection

• ArboShield™ HR-symbionts spread naturally, both vertically (eggs), and horizontally (mating), creating ecosystem-scale immunization that protects vectors, humans, and wildlife simultaneously.

ArboShield™ HR-symbiont infected mosquitoes are produced by Vacunax for deployment to geographic areas where pathogens are causing disease outbreak.